Insider Transactions in Q3 2025 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
962
-2.09%
|
$6,734
$7.77 P/Share
|
|
Sep 21
2025
|
Mark Verratti Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-0.28%
|
$7,595
$7.77 P/Share
|
|
Sep 21
2025
|
Margaret Ancona EVP, Strategy & Transformation |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-0.74%
|
$6,706
$7.77 P/Share
|
|
Sep 21
2025
|
Benjamin Richard Wheeler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,559
-2.69%
|
$17,913
$7.77 P/Share
|
|
Sep 03
2025
|
Jennifer Lynne Fox Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,435
-3.55%
|
$26,610
$6.8 P/Share
|
|
Aug 16
2025
|
Benjamin Richard Wheeler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+38.66%
|
-
|